Brodalumab in Patients Who Had Inadequate Response to Ustekinumab

British Journal of Dermatology - United Kingdom
doi 10.1111/bjd.17471
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Transition to Ustekinumab in Patients With Moderate-To-Severe Psoriasis and Inadequate Response to Methotrexate: A Randomized Clinical Trial (TRANSIT)

British Journal of Dermatology
DermatologyMedicine
2014English

Increase in Methotrexate Dose in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Infliximab

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2005English

Pss17 - Cost Per Responder Analysis of Brodalumab Compared With Ustekinumab in the Treatment of Moderate-To-Severe Plaque Psoriasis in Canada

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients With Crohn's Disease

Gastroenterology
HepatologyGastroenterology
2018English

Inadequate Antibody Response to Rabies Vaccine in Immunocompromised Patient

Emerging Infectious Diseases
EpidemiologyInfectious DiseasesMicrobiology
2012English

RESPITE: Switching to Riociguat in Pulmonary Arterial Hypertension Patients With Inadequate Response to Phosphodiesterase-5 Inhibitors

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2017English

Impact of Previous Biologic Use on Efficacy and Safety of Brodalumab and Ustekinumab in Patients With Moderate-To-Severe Plaque Psoriasis: Integrated Analysis of AMAGINE-2 and AMAGINE-3

British Journal of Dermatology
DermatologyMedicine
2018English

Population Pharmacokinetics of Brodalumab in Patients With Moderate to Severe Plaque Psoriasis

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2019English

Effect of Prior Biologic Use on Cost-Effectiveness of Brodalumab vs. Ustekinumab for Treatment of Moderate-To-Severe Psoriasis in the United States

Dermatology and Therapy
Dermatology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy